Given the safety and efficacy of current vaccines and antibiotics, there are not a large number of new agents under development to treat<unk> .
Anthrax future or investigational therapies
Anthrax medical therapy
Mast cell leukemia medical therapy
Typhus medical therapy
Non-Hodgkin lymphoma medical therapy
Cytomegalovirus medical therapy
Hodgkin's lymphoma medical therapy
Appendix cancer medical therapy